Cargando…

The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study

BACKGROUND: Familial hypercholesterolemia (FH) is a genetic disorder characterized by high levels of low-density lipoprotein cholesterol (LDL-C). Because of underdiagnosis, acute coronary syndrome (ACS) is often the first clinical manifestation of FH. In Japan, there are few reports on the prevalenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Teramoto, Tamio, Sawa, Tomohiro, Iimuro, Satoshi, Inomata, Hyoe, Koshimizu, Takashi, Sakakibara, Iori, Hiramatsu, Katsutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321519/
https://www.ncbi.nlm.nih.gov/pubmed/32636924
http://dx.doi.org/10.1155/2020/5936748
_version_ 1783551485737435136
author Teramoto, Tamio
Sawa, Tomohiro
Iimuro, Satoshi
Inomata, Hyoe
Koshimizu, Takashi
Sakakibara, Iori
Hiramatsu, Katsutoshi
author_facet Teramoto, Tamio
Sawa, Tomohiro
Iimuro, Satoshi
Inomata, Hyoe
Koshimizu, Takashi
Sakakibara, Iori
Hiramatsu, Katsutoshi
author_sort Teramoto, Tamio
collection PubMed
description BACKGROUND: Familial hypercholesterolemia (FH) is a genetic disorder characterized by high levels of low-density lipoprotein cholesterol (LDL-C). Because of underdiagnosis, acute coronary syndrome (ACS) is often the first clinical manifestation of FH. In Japan, there are few reports on the prevalence and diagnostic ratios of FH and the proportion of ACS among FH patients in clinical settings. METHODS: This retrospective, observational study used anonymized data from electronic healthcare databases between April 2001 and March 2015 of patients who had ≥2 LDL-C measurements recorded after April 2009. The index date was defined as the date of the first LDL-C measurement after April 2009. The primary endpoint was the prevalence of definite or suspected FH; secondary endpoints included the proportion of FH patients hospitalized for ACS, the proportion of patients using lipid-lowering drugs (LLDs), and LDL-C levels. RESULTS: Of the 187,781 patients screened, 1547 had definite or suspected FH (0.8%) based on data from the entire period; 832 patients with definite (n = 299, 0.16%) or suspected FH (n = 533, 0.28%) before the index date were identified in the main analysis cohort. LLDs were used in 214 definite FH patients (71.6%) and 137 suspected FH patients (25.7%). Among definite or suspected FH patients with ACS (n = 84) and without ACS (n = 748), 32.1% and 30.1% with definite FH and 3.2% and 2.4% with suspected FH had LDL-C levels < 2.6 mmol/L (<100 mg/dL), respectively. Sixty patients (7.2%) were hospitalized due to ACS at the index date. CONCLUSIONS: The prevalence of FH in this Japanese cohort of patients with ≥2 LDL-C measurements at hospitals was 0.8%, which is higher than that currently reported in epidemiological studies (0.2–0.5%). Patients with suspected FH, with or without ACS, had poorly controlled LDL-C levels and were undertreated. The proportion of FH patients who were hospitalized due to ACS was 7.2%.
format Online
Article
Text
id pubmed-7321519
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-73215192020-07-06 The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study Teramoto, Tamio Sawa, Tomohiro Iimuro, Satoshi Inomata, Hyoe Koshimizu, Takashi Sakakibara, Iori Hiramatsu, Katsutoshi Cardiovasc Ther Research Article BACKGROUND: Familial hypercholesterolemia (FH) is a genetic disorder characterized by high levels of low-density lipoprotein cholesterol (LDL-C). Because of underdiagnosis, acute coronary syndrome (ACS) is often the first clinical manifestation of FH. In Japan, there are few reports on the prevalence and diagnostic ratios of FH and the proportion of ACS among FH patients in clinical settings. METHODS: This retrospective, observational study used anonymized data from electronic healthcare databases between April 2001 and March 2015 of patients who had ≥2 LDL-C measurements recorded after April 2009. The index date was defined as the date of the first LDL-C measurement after April 2009. The primary endpoint was the prevalence of definite or suspected FH; secondary endpoints included the proportion of FH patients hospitalized for ACS, the proportion of patients using lipid-lowering drugs (LLDs), and LDL-C levels. RESULTS: Of the 187,781 patients screened, 1547 had definite or suspected FH (0.8%) based on data from the entire period; 832 patients with definite (n = 299, 0.16%) or suspected FH (n = 533, 0.28%) before the index date were identified in the main analysis cohort. LLDs were used in 214 definite FH patients (71.6%) and 137 suspected FH patients (25.7%). Among definite or suspected FH patients with ACS (n = 84) and without ACS (n = 748), 32.1% and 30.1% with definite FH and 3.2% and 2.4% with suspected FH had LDL-C levels < 2.6 mmol/L (<100 mg/dL), respectively. Sixty patients (7.2%) were hospitalized due to ACS at the index date. CONCLUSIONS: The prevalence of FH in this Japanese cohort of patients with ≥2 LDL-C measurements at hospitals was 0.8%, which is higher than that currently reported in epidemiological studies (0.2–0.5%). Patients with suspected FH, with or without ACS, had poorly controlled LDL-C levels and were undertreated. The proportion of FH patients who were hospitalized due to ACS was 7.2%. Hindawi 2020-06-11 /pmc/articles/PMC7321519/ /pubmed/32636924 http://dx.doi.org/10.1155/2020/5936748 Text en Copyright © 2020 Tamio Teramoto et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Teramoto, Tamio
Sawa, Tomohiro
Iimuro, Satoshi
Inomata, Hyoe
Koshimizu, Takashi
Sakakibara, Iori
Hiramatsu, Katsutoshi
The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study
title The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study
title_full The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study
title_fullStr The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study
title_full_unstemmed The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study
title_short The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study
title_sort prevalence and diagnostic ratio of familial hypercholesterolemia (fh) and proportion of acute coronary syndrome in japanese fh patients in a healthcare record database study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321519/
https://www.ncbi.nlm.nih.gov/pubmed/32636924
http://dx.doi.org/10.1155/2020/5936748
work_keys_str_mv AT teramototamio theprevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT sawatomohiro theprevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT iimurosatoshi theprevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT inomatahyoe theprevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT koshimizutakashi theprevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT sakakibaraiori theprevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT hiramatsukatsutoshi theprevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT teramototamio prevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT sawatomohiro prevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT iimurosatoshi prevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT inomatahyoe prevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT koshimizutakashi prevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT sakakibaraiori prevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy
AT hiramatsukatsutoshi prevalenceanddiagnosticratiooffamilialhypercholesterolemiafhandproportionofacutecoronarysyndromeinjapanesefhpatientsinahealthcarerecorddatabasestudy